Aspire Biopharma Holdings, Inc. (ASBP) — Dilution Risk Analysis

Current Snapshot

Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionWatch score of 61/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
1,402,557 Source
Public Float
1,200,954 Source
Float as % of Outstanding
85.6%

Dilution Risk Score

Score: 61/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: SC 13G/A 2, 8-K 3, SC 13G 2, 8-K/A 1, EFFECT 1, S-1/A 1.

FormFiledAccession
SC 13G/A 2026-08-14 0000919574-26-005317
8-K 2026-08-10 0001493152-26-036777
SC 13G 2026-08-10 0001213900-26-087424
SC 13G/A 2026-08-06 0001493152-26-036445
SC 13G 2026-07-02 0002142929-26-000001
8-K 2026-06-22 0001493152-26-029599
8-K/A 2026-04-17 0001493152-26-017145
8-K 2026-04-16 0001493152-26-017115
EFFECT 2026-04-14 9999999995-26-001178
S-1/A 2026-04-10 0001493152-26-016123

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $20,000,000 Source
Cash runway 20 months Source
Three-year share count growth 12.78% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 61/10) Source
Cash Runway
20 months Source
Shelf Registration Capacity
$20,000,000 Source
Share Count Growth (3-Year)
12.78% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.